Safety and immunogenicity of a randomized phase I prime-boost trial with ALVAC-HIV (vCP205) and gp160 MN/LAI-2 adjuvanted in alum or polyphosphazene

Tekijä O'Connell, RJ, Polonis, VR, Ratto-Kim, S, Cox, J, Jagodzinski, LL, Malia, J, Michael, NL, Excler, J, Robb, ML, Kim, JH
Julkaistu 2012

P10-12. Altered NK cell phenotype and function in Ugandans with chronic HIV-1 infection

Tekijä Eller, MA, Eller, L, Koehler, RN, Kijak, GH, Guwatudde, D, Marovich, MA, Michael, NL, de Souza, MS, Wabwire-Mangen, F, Robb, ML, Currier, JR, Sandberg, JK
Julkaistu 2009

S011-05 OA. HLA-A*7401 is associated with protection from HIV-1 acquisition and disease progression in Mbeya, Tanzania

Tekijä Koehler, RN, Walsh, AM, Saathoff, E, Currier, JR, Bautista, CT, Moqueet, N, Ratto-Kim, S, Maboko, L, Hoelscher, M, Robb, ML, Michael, NL, McCutchan, FE, Kim, JH, Kijak, GH
Julkaistu 2009

P08-03. Genetic complexity of TRIM5 and APOBEC in East Africa

Tekijä Walsh, AM, Perret, K, Koehler, R, Moqueet, N, Bautista, C, Eller, L, Eller, M, Kibuuka, H, Hoelscher, M, Maboko, L, Wabwire-Mangen, F, Robb, ML, Michael, NL, McCutchan, F, Kim, J, Kijak, GH
Julkaistu 2009

P04-28. Breadth and magnitude of neutralizing antibody responses in subjects infected with HIV-1 subtype D or recombinants in Rakai district, Uganda

Tekijä Eller, L, Ouma, B, Oballah, P, Eller, MA, de Souza, MS, Wabwire-Mangen, F, Laeyendecker, O, Quinn, T, Kiwanuka, N, Serwadda, D, Sewankambo, N, Wawer, M, Gray, R, Michael, NL, Robb, ML, Montefiori, D, Brown, BK, Polonis, VR
Julkaistu 2009

T-cell based sieve analysis ties HLA A*02 to vaccine efficacy and IgA-C1 immune correlate in RV144 Thai trial

Tekijä Hertz T, Gartland A, Janes H, Li S, Fong Y, Tomaras GD, Morris D, Geraghty D, Kijak GH, Edlefsen PT, Rolland M, Larsen BB, Tovanabutra S, Sanders-Buell E, DeCamp AC, Magaret CA, Ahmed H, Nariya S, Wong K, Zhao H, Deng W, Maust BS, Bose M, Howell S, Lazzaro M, Bates A, Lei E, Bradfield A, Ibitamuno G, Assawadarachai V, O'Connel RJ, deSouza MS, Nitayaphan S, Rerks-Ngarm S, Robb ML, McElrath MJ, Haynes BF, Michael NL, Gilbert PB, Mullins JI, Kim JH
Julkaistu 2012-09-01

T-cell based sieve analysis ties HLA A*02 to vaccine efficacy and IgA-C1 immune correlate in RV144 Thai trial

Tekijä Hertz, T, Gartland, A, Janes, H, Li, S, Fong, Y, Tomaras, GD, Morris, D, Geraghty, D, Kijak, GH, Edlefsen, PT, Rolland, M, Larsen, BB, Tovanabutra, S, Sanders-Buell, E, DeCamp, AC, Magaret, CA, Ahmed, H, Nariya, S, Wong, K, Zhao, H, Deng, W, Maust, BS, Bose, M, Howell, S, Lazzaro, M, Bates, A, Lei, E, Bradfield, A, Ibitamuno, G, Assawadarachai, V, O'Connel, RJ, deSouza, MS, Nitayaphan, S, Rerks-Ngarm, S, Robb, ML, McElrath, MJ, Haynes, BF, Michael, NL, Gilbert, PB, Mullins, JI, Kim, JH
Julkaistu 2012